037sek
1,4 %
Date:2025-01-22Time:16:10:13Latest report:Q4-2023List:First NorthTicker:2CUREX
Market Cap:9 msekEnterprise Value:-4 msekNet Sales:0,16 msekEarnings:-30,8 msekEmployees:0ISIN:SE0010468124

Ratios

10-year key figure history for 2cureX turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for 2cureX with index and moving average MA50 and MA200.

Stockprice:0,36
MA50:0,44
MA200:0,48
Price/MA200:-24,2 %
RSI (14):43,2
Price/MA50:-17,5 %

Description

2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.

Medical Equipment